LAMP2 Gene

LAMP2 Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">LAMP2 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>LAMP2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Lysosomal Associated Membrane Protein 2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Xq24 (ChrX: 119,769,452-119,810,423)</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>3990</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>300256</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000143106</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>P13473</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>Medium-High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Striatum</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-LAMP2 delivery</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>Autophagy enhancers</td>
</tr>
<tr>
<td class="label">Protein replacement</td>
<td>Recombinant LAMP2</td>
</tr>
<tr>
<td class="label">Chaperones</td>
<td>En

LAMP2 Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">LAMP2 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>LAMP2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Lysosomal Associated Membrane Protein 2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Xq24 (ChrX: 119,769,452-119,810,423)</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>3990</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>300256</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000143106</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>P13473</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>Medium-High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Striatum</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-LAMP2 delivery</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>Autophagy enhancers</td>
</tr>
<tr>
<td class="label">Protein replacement</td>
<td>Recombinant LAMP2</td>
</tr>
<tr>
<td class="label">Chaperones</td>
<td>Enhance CMA activity</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">629 edges</a></td>
</tr>
</table>

Lamp2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Pathway Diagram

Overview

Function

LAMP2 encodes Lysosomal Associated Membrane Protein 2, a major lysosomal membrane glycoprotein essential for lysosomal function, autophagy, and chaperone-mediated autophagy (CMA).

Molecular Functions

• Lysosomal membrane integrity: Major structural protein
• Chaperone-mediated autophagy (CMA): Receptor for cytosolic proteins
• Macroautophagy: Involved in autophagosome-lysosome fusion
• Phagocytosis: Facilitates cellular debris clearance
• Cholesterol trafficking: Regulates cellular cholesterol homeostasis

Structure

• Type I transmembrane glycoprotein
• Large lumenal domain (N-terminal)
• Short cytoplasmic tail (C-terminal)
• Heavily glycosylated (N-linked glycans)

Expression

• Ubiquitously expressed
• Highest in liver, brain, heart, skeletal muscle
• In brain: [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), [microglia](/entities/microglia)
• Three splice variants: LAMP2A (CMA), LAMP2B, LAMP2C

Disease Associations

Danon Disease

• X-linked dominant storage disorder
• Caused by LAMP2 mutations (typically nonsense/frameshift)
• Triad: cardiomyopathy, skeletal myopathy, intellectual disability
• Hypertrophic cardiomyopathy in males (often fatal)
• Presents in adolescence/young adulthood

Parkinson's Disease

• LAMP2A dysfunction implicated in PD pathogenesis
• Reduced CMA activity in PD brain
• Accumulation of autophagic substrates
• Interaction with [alpha-synuclein](/mechanisms/alpha-synuclein) metabolism

Alzheimer's Disease

• LAMP2 decreases with aging and AD
• Impaired autophagic-lysosomal pathway in AD
• Role in [Aβ](/proteins/amyloid-beta) and [tau](/proteins/tau) clearance
• Potential therapeutic target

ALS

• Altered LAMP2 expression in ALS
• [Autophagy](/entities/autophagy) dysregulation in motor neurons
• May modify disease progression

Lysosomal Storage Diseases

• Danon disease shares features with other LSDs
• May have overlapping therapeutic approaches

Therapeutic Targeting

Gene Therapy

• AAV-LAMP2B being developed for Danon disease
• Studies in mouse models show promise

Small Molecule Approaches

• Autophagy-enhancing compounds
• CMA modulators in development

Protein Replacement

• Investigational recombinant LAMP2 protein
• Challenges: delivery to lysosomes

Key Publications

Background

The study of Lamp2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Allen Brain Atlas Data

Gene Expression

• Hippocampus - High expression in pyramidal neurons
• Cerebral cortex - High expression in layer 5 neurons
• Substantia nigra - Moderate-high expression in dopaminergic neurons
• Heart - High expression (relevant for Danon disease)

Single-Cell Expression

• Neurons (pyramidal cells)
• Dopaminergic neurons
• Cardiomyocytes
• All cell types (ubiquitous lysosomal protein)

Brain Region Expression Levels

See Also

• [LAMP1 Gene - Related lysosomal protein](/proteins/lamp1)
• Danon Disease
• [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosome-neurodegeneration)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)

References

External Links

• [NCBI Gene: LAMP2](https://www.ncbi.nlm.nih.gov/gene/3990)
• [UniProt: P13473](https://www.uniprot.org/uniprot/P13473)
• [OMIM: 300256](https://www.omim.org/entry/300256)
• [Danon Disease Foundation](https://danondisease.org/)

Expression Pattern

LAMP2 demonstrates broad tissue distribution with particularly high expression in:

• [Heart muscle](/institutions/usc)
• [Skeletal muscle](/cell-types/skeletal-muscle-cells)
• [Liver](/technologies/exosome-cns-delivery)
• [Kidney](/cell-types/medullary-kidney-shaped-neurons)
• [Brain (neurons and glia)](/cell-types/neurons)

Isoforms

The LAMP2 gene produces multiple isoforms through alternative splicing:

• [LAMP2A](/proteins/lamp2): Major isoform involved in chaperone-mediated autophagy (CMA)
• LAMP2B: Predominant in skeletal and cardiac muscle
• LAMP2C: Expressed in various tissues, function less characterized

Role in Autophagy

Chaperone-Mediated Autophagy

LAMP2A forms multimeric complexes in the lysosomal membrane that recognize proteins containing a specific pentapeptide motif (KFERQ). This allows selective degradation of cytosolic proteins without membrane disruption.

Macroautophagy

LAMP2 participates in general autophagosome-lysosome fusion, though this function is more associated with LAMP2B.

Xenophagy

LAMP2 helps target intracellular pathogens for lysosomal degradation, contributing to cellular defense.

Disease Associations

Danon Disease

LAMP2 mutations cause Danon disease, an X-linked lysosomal storage disorder characterized by:

• Cardiomyopathy
• Skeletal myopathy
• Intellectual disability
• Visual impairment

Parkinson's Disease

Reduced LAMP2 expression has been observed in PD brains, potentially contributing to:

• Alpha-synuclein accumulation
• Impaired autophagy
• Lysosomal dysfunction
• Mitochondrial abnormalities

Alzheimer's Disease

LAMP2 involvement in AD includes:

• Amyloid-beta clearance
• Tau degradation
• Autophagy-lysosomal pathway dysfunction
• Neuronal vulnerability

ALS

LAMP2 alterations may contribute to ALS pathogenesis through:

• Protein aggregation
• Impaired autophagy
• Motor neuron vulnerability

Therapeutic Strategies

Animal Models

LAMP2 knockout mice exhibit:

• Cardiomyopathy
• Myopathy
• Accumulation of autophagic material
• Premature death (severe phenotypes)

Key Publications

[@cuervo2004]: Cuervo AM, et al. (2004). "Impairment of chaperone-mediated autophagy in aging and neurodegeneration." Aging Cell 3(6): 313-317.

[@rothenberg2010]: Rothenberg C, et al. (2010). "LAMP2 improves cellular function[^6]: Wang Y, et al. (2016). "LAMP2 in Alzheimer's disease and related disorders." Journal of Alzheimer's Disease 51(4): 1021-1032.

Pathway Diagram

The following diagram shows the key molecular relationships involving LAMP2 Gene discovered through SciDEX knowledge graph analysis: